Bridges Girl

I received an email about a clinical trial this week that I thought sounded interesting and thought I would share.  Here is a portion of what was sent to me.  I hope by passing this information along, I can increase awareness of other types of Breast Cancer.  I know too well that all breast cancers aren’t the same and this is one I hadn’t heard of until now. 

Celsion Corporation launched a program this week to increase awareness of a clinical trial for Recurrent Chest Wall (RCW) Breast Cancer, a condition that affects up to 40% of women who undergo a mastectomy. The prognosis for these patients is poor, with most going on to develop metastatic disease, and there are limited treatment options available. The pivotal Phase I/II DIGNITY clinical trial is evaluating the use of ThermoDox® in combination with hyperthermia for the treatment of RCW Breast Cancer. In early studies, conducted at Duke University Medical Center, investigators report that ThermoDox® has demonstrated significant promise in treating this highly aggressive disease.

The DIGNITY study is being conducted at 7 sites across the country, including: Rhode Island Hospital, Providence, RI; Florida Cancer Institute, Hudson, FL; New York University Hospital, New York, NY; Saint Barnabas Medical Center, Livingston, NJ; Duke University Health System, Durham, NC; Virginia Commonwealth University – Medical Center, Richmond, VA; and Cancer Treatment Center of America, Tulsa, OK.

More information about the DIGNITY trial can be found at:

http://www2.prnewswire.com/mnr/celsion/39944/

 In addition to the link above, they can also go to www.celsion.com and www.clinicaltrials.gov for more information.

Tweet This Post